icon

+8615898659128

Bank of China Tower, 200 Yincheng Middle Road, Lujiazui, Pudong New Area, Shanghai

FIPRecover Announces Expansion of Production Capacity to Meet Growing Demand for FIP Therapies

FIPRecover Biotechnology Co., Ltd., a leading specialist in feline antiviral pharmaceuticals, today announced a significant expansion of its manufacturing capabilities.

This strategic investment is driven by the increasing global need for accessible, high-quality treatments for Feline Infectious Peritonitis (FIP). The enhanced facility will incorporate advanced technologies to scale up the production of its core drugs, GS441524 and Molnupiravir, while further solidifying its stringent quality control protocols. “Our mission is to give every cat with FIP a fighting chance,” said a company spokesperson. “This expansion ensures we can reliably supply our clinically proven therapies to more veterinarians and pet families worldwide, without ever compromising on the safety and efficacy standards that define our products.”

Social Share

Related Post

FIP Medication Shipping to Europe: Delivery, Customs and What Buyers Should Confirm
20th November 2026

FIP Medication Shipping to Europe: Delivery, Customs and What Buyers Should Confirm

FIP medication shipping to Europe via DHL, FedEx and UPS in 10-12 days, with double clearance channels, protective packaging and batch COA verification for buyers.

Private Label FIP Medication: OEM and ODM Options for Veterinary Brands
19th November 2026

Private Label FIP Medication: OEM and ODM Options for Veterinary Brands

Build a private label FIP line with GS-441524 and Molnupiravir OEM: your brand on vials and tablets, per-batch HPLC testing, COA, MSDS and flexible 1-25 kg packs.

Post Comment